Russian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Vitamin E for Extremely Preterm Infants

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Ссылка сохраняется в буфер обмена
СтатусЗавершено
Спонсоры
NICHD Neonatal Research Network
Соавторы
National Center for Research Resources (NCRR)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Ключевые слова

абстрактный

The purpose of this pilot trial is to test the safety and efficacy of administering one dose of vitamin E, via a tube into the stomach, to extremely preterm infants (less than 27 weeks gestation and less than 1000 grams birth weight). This pilot will examine whether a single dose of vitamin E will be absorbed into the infants' bloodstreams with resulting serum α-tocopherol level in the target range of 1-3 mg/dl.

Описание

Intraventricular hemorrhage (IVH) -- bleeding into the brain's ventricular system -- is one of the most common complications of prematurity, affecting an estimated 10-40% of very low birth weight (<1500 g) infants born at less than 35 weeks of gestation. Mortality from severe (high-grade) IVH is 27-50%. Severe IVH can result in developmental delays and life-long neurological deficits, including cerebral palsy and seizures.

A number of strategies have been used in efforts to prevent IVH, including: antenatal corticosteroids, maternal vitamin K, delayed clamping of the umbilical cord, indomethacin, ethamsylate, inositol, and muscle paralysis. With the exception of antenatal corticosteroids and indomethacin, these measures have met with only limited success. Supplemental vitamin E, given in the first few hours of life to all premature infants, offers a promising low-risk approach to preventing and/or lessening the severity of IVH.

This safety and efficacy pilot trial will examine whether one dose of vitamin E (dl-α-tocopheryl acetate), given intragastrically to preterm infants <27 weeks gestation and <1000 grams birth weight, will produce blood serum α-tocopherol levels in the target range of 1-3 mg/dl. Based on the results of this pilot, a Phase III randomized control trial will be developed to test whether a single dose of vitamin E can reduce the incidence of death or neurodevelopmental impairment at 18-22 months corrected age in these preterm infants.

Most intraventricular hemorrhages occur in the first 72 hours after birth. Because of this, to prevent IVH, it must be given as soon as possible after birth. Eligible, consented infants will be assigned to either a vitamin E group or a placebo group. Infants in the vitamin E group will receive 1.0 ml/kg of dl-α-tocopheryl acetate (Aquasol E®); infants in the placebo control group will receive a similar amount of sterile water. The dose will be given within 4 hours of birth via a tube into the stomach. Blood samples will be taken from all infants before the dose is given, 24 hours after dosing, and 7 days after dosing to measure how well the vitamin E is absorbed into the bloodstream.

Даты

Последняя проверка: 10/31/2015
Первый отправленный: 08/30/2010
Предполагаемая регистрация отправлена: 08/30/2010
Первое сообщение: 08/31/2010
Последнее обновление отправлено: 11/09/2015
Последнее обновление опубликовано: 11/10/2015
Фактическая дата начала исследования: 09/30/2010
Предполагаемая дата завершения начальной школы: 07/31/2011
Предполагаемая дата завершения исследования: 07/31/2011

Состояние или болезнь

Infant, Newborn
Infant, Small for Gestational Age
Infant, Very Low Birth Weight
Infant, Premature
Intracranial Hemorrhages

Вмешательство / лечение

Drug: Vitamin E

Drug: Placebo

Фаза

Фаза 1

Группы рук

РукаВмешательство / лечение
Experimental: Vitamin E
A single intragastric dose of dl-α-tocopheryl acetate (Aquasol E®) 50 IU/kg.
Drug: Vitamin E
A single intragastric dose of dl-α-tocopheryl acetate 50 IU/kg.
Placebo Comparator: Placebo
Sterile water in volume equal to that of the comparator drug.
Drug: Placebo
Sterile water in volume equal to that of the comparator drug

Критерии приемлемости

Полы, имеющие право на обучениеAll
Принимает здоровых добровольцевда
Критерии

Inclusion Criteria:

- Less than 27 completed weeks gestational age

- Birth weight less than 1,000 grams

- Inborn infants

Exclusion Criteria:

- Infant's treatment will be limited based on poor prognosis

- Umbilical cord or blood pH below 7.0

- Antenatally diagnosed brain abnormality, including hemorrhage

- Major congenital malformations, including those for which feeding is contraindicated

- Mother of infant enrolled in a clinical trial of vitamin E supplementation

- Mother of infant reports self administration of monovitamin supplements of vitamin E during pregnancy or labor

- Infant has received supplemental vitamin E (except multivitamin additive in parenteral nutrition or through enteral milk or formula feeds)

- Greater than four hours of age

Результат

Основные показатели результатов

1. Serum tocopherol levels [Birth to 7 days]

Blood samples will be tested for tocopherol levels at baseline, 24 hours, and 7 days.

Присоединяйтесь к нашей
странице facebook

Самая полная база данных о лекарственных травах, подтвержденная наукой

  • Работает на 55 языках
  • Травяные лекарства, подтвержденные наукой
  • Распознавание трав по изображению
  • Интерактивная карта GPS - отметьте травы на месте (скоро)
  • Прочтите научные публикации, связанные с вашим поиском
  • Ищите лекарственные травы по их действию
  • Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов

Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.

Google Play badgeApp Store badge